Immunoprecise Antibodies Share Price Today
(NASDAQ: IPA)

Name: Immunoprecise Antibodies Share Price Today (NASDAQ: IPA) - Immunoprecise Antibodies Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Immunoprecise Antibodies share price is $0.39 & ₹33.92 as on 6 Mar 2025, 2.30 'hrs' IST

$0.39

▲

0.04

(11.74%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Immunoprecise Antibodies share price in Dollar and Rupees. Guide to invest in Immunoprecise Antibodies stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Immunoprecise Antibodies, along with analyst recommendations, forecasts, and comprehensive financials.

Immunoprecise Antibodies share price movements

Today's Low: $0.33
Today's High: $0.40
$0.39
15.13%
Downside
Day's Volatility :17.8%
Upside
3.15%
52 Weeks Low: $0.27
52 Weeks High: $2.43
$0.39
30.77%
Downside
52 Weeks Volatility :88.89%
Upside
83.95%

Immunoprecise Antibodies (IPA) Returns

Period	Immunoprecise Antibodies Ltd	Index (Russel 2000)
3 Months	7.39%	0.0%
6 Months	-41.22%	0.0%
1 Year	-75.06%	0.0%
3 Years	-90.57%	-11.6%

Immunoprecise Antibodies (IPA) Key Statistics

in dollars & INR

Previous Close	$0.3526
Open	$0.35
Today's High	$0.4027
Today's Low	$0.331
Market Capitalization	$16.1M
Today's Volume	$961.5K
52 Week High	$2.4299
52 Week Low	$0.27
Revenue TTM	$24.1M
EBITDA	$-12.2M
Earnings Per Share (EPS)	$-0.79
Profit Margin	-115.93%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-65.88%

How to invest in Immunoprecise Antibodies Stock (IPA) from India?

It is very easy for Indian residents to invest directly in Immunoprecise Antibodies from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Immunoprecise Antibodies stock in both Indian Rupees (INR) and US Dollars (USD). Search for Immunoprecise Antibodies or IPA on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Immunoprecise Antibodies or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Immunoprecise Antibodies shares which would translate to 2.230 fractional shares of Immunoprecise Antibodies as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Immunoprecise Antibodies, in just a few clicks!

Returns in Immunoprecise Antibodies (IPA) for Indian investors in Rupees

The Immunoprecise Antibodies stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Immunoprecise Antibodies investment value today

Current value as on today

₹29,632

Returns

₹70,368

(-70.37%)

Returns from Immunoprecise Antibodies Stock

₹75,316 (-75.32%)

Dollar Returns

₹4,949 (+4.95%)

Indian investors sentiment towards Immunoprecise Antibodies (IPA)

-89%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Immunoprecise Antibodies Stock from India on INDmoney has decreased by -89% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Immunoprecise Antibodies

Analyst Recommendation on Immunoprecise Antibodies

Buy

83%Buy

16%Hold

0%Sell

Based on 6 Wall street analysts offering stock ratings for Immunoprecise Antibodies(by analysts ranked 0 to 5 stars)

Based on 6 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Immunoprecise Antibodies Stock (IPA)

What analysts predicted

Upside of 1182.05%

Target:

$5.00

Current:

$0.39

Insights on Immunoprecise Antibodies Stock (Ticker Symbol: IPA)

Price Movement
In the last 7 days, IPA stock has moved up by 17.6%
Increasing Revenue
Revenue is up for the last 2 quarters, 5.26M → 6.12M (in $), with an average increase of 14.1% per quarter
Increasing Net Profit
Netprofit is up for the last 3 quarters, -18.04M → -2.55M (in $), with an average increase of 203.9% per quarter
IPA vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 66.5% return, outperforming this stock by 141.6%
IPA vs VRTX (3 yr)
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 51.6% return, outperforming this stock by 142.8%
Price to Sales
ForIPA every $1 of sales, investors are willing to pay $0.4, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.2 for every $1 of sales.

IPA Immunoprecise Antibodies Financials in INR & Dollars

	FY19	Y/Y Change
Revenue	$8.2M	↑ 100.8%
Net Income	$-5.7M	↑ 47.31%
Net Profit Margin	-69.72%	↑ 25.31%

	FY20	Y/Y Change
Revenue	$10.0M	↑ 28.66%
Net Income	$-3.5M	↓ 35.05%
Net Profit Margin	-35.19%	↑ 34.53%

	FY21	Y/Y Change
Revenue	$14.3M	↑ 27.42%
Net Income	$-5.9M	↑ 48.36%
Net Profit Margin	-40.98%	↓ 5.79%

	FY22	Y/Y Change
Revenue	$15.3M	↑ 8.11%
Net Income	$-13.2M	↑ 127.64%
Net Profit Margin	-86.29%	↓ 45.31%

	FY23	Y/Y Change
Revenue	$15.3M	↑ 6.72%
Net Income	$-19.7M	↑ 58.96%
Net Profit Margin	-128.53%	↓ 42.24%

	FY24	Y/Y Change
Revenue	$17.9M	↑ 18.65%
Net Income	$-19.9M	↑ 2.32%
Net Profit Margin	-110.85%	↑ 17.68%

	Q3 FY23	Q/Q Change
Revenue	$3.5M	↓ 16.58%
Net Income	$-7.1M	↑ 82.9%
Net Profit Margin	-200.06%	↓ 108.81%

	Q4 FY23	Q/Q Change
Revenue	$4.5M	↑ 31.16%
Net Income	$-1.9M	↓ 72.05%
Net Profit Margin	-42.63%	↑ 157.43%

	Q1 FY24	Q/Q Change
Revenue	$4.6M	↑ 0.0%
Net Income	$-2.0M	↑ 0.0%
Net Profit Margin	-42.63%	↑ 0.0%

	Q2 FY24	Q/Q Change
Revenue	$4.7M	↑ 5.02%
Net Income	$-13.2M	↑ 588.22%
Net Profit Margin	-279.38%	↓ 236.75%

	Q3 FY24	Q/Q Change
Revenue	$3.8M	↓ 18.52%
Net Income	$-2.9M	↓ 77.84%
Net Profit Margin	-75.98%	↑ 203.4%

	Q4 FY24	Q/Q Change
Revenue	$6.1M	↑ 16.38%
Net Income	$-2.6M	↓ 36.16%
Net Profit Margin	-41.68%	↑ 34.3%

	FY19	Y/Y Change
Profit	$4.0M	↑ 116.02%

	FY20	Y/Y Change
Profit	$5.7M	↑ 51.74%

	FY21	Y/Y Change
Profit	$9.2M	↑ 43.61%

	FY22	Y/Y Change
Profit	$8.7M	↓ 4.81%

	FY23	Y/Y Change
Profit	$8.6M	↑ 5.28%

	FY24	Y/Y Change
Profit	$8.8M	↑ 4.24%

	Q3 FY23	Q/Q Change
Profit	$1.9M	↓ 25.8%

	Q4 FY23	Q/Q Change
Profit	$2.2M	↑ 19.16%

	Q1 FY24	Q/Q Change
Profit	$2.2M	↑ 0.0%

	Q2 FY24	Q/Q Change
Profit	$2.3M	↑ 5.21%

	Q3 FY24	Q/Q Change
Profit	$1.7M	↓ 24.2%

	Q4 FY24	Q/Q Change
Profit	$3.4M	↑ 45.88%

	FY19	Y/Y Change
Operating Cash Flow	$-2.4M	↓ 6.14%
Investing Cash Flow	$-1.6M	↓ 69.3%
Financing Cash Flow	$7.0M	↓ 4.59%

	FY20	Y/Y Change
Operating Cash Flow	$-990.1K	↓ 56.61%
Investing Cash Flow	$-1.1M	↓ 28.1%
Financing Cash Flow	$124.3K	↓ 98.13%

	FY21	Y/Y Change
Operating Cash Flow	$-480.0K	↓ 56.87%
Investing Cash Flow	$-2.0M	↑ 55.14%
Financing Cash Flow	$34.7M	↑ 24730.42%

	FY22	Y/Y Change
Operating Cash Flow	$-7.9M	↑ 1553.5%
Investing Cash Flow	$-4.1M	↑ 112.05%
Financing Cash Flow	$2.3M	↓ 93.35%

	FY23	Y/Y Change
Operating Cash Flow	$-14.7M	↑ 99.91%
Investing Cash Flow	$-1.5M	↓ 62.23%
Financing Cash Flow	$-460.7K	↓ 121.54%

	Q3 FY23	Q/Q Change
Operating Cash Flow	$-7.8M	↑ 361.68%
Investing Cash Flow	$-149.0K	↓ 55.63%
Financing Cash Flow	$-115.0K	↓ 60.1%

Immunoprecise Antibodies Technicals Summary

Sell

Neutral

Buy

Immunoprecise Antibodies is currently in a neutral trading position according to technical analysis indicators.

Immunoprecise Antibodies (IPA) Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Immunoprecise Antibodies Ltd	-15.45%	-41.22%	-75.06%	-90.57%	-97.53%
Regeneron Pharmaceuticals, Inc.	-1.42%	-40.28%	-29.31%	11.08%	44.83%
Beone Medicines Ltd	17.63%	36.87%	64.37%	45.89%	71.3%
Vertex Pharmaceuticals Incorporated	1.94%	4.92%	19.37%	108.73%	123.83%
Alnylam Pharmaceuticals, Inc.	-8.03%	-0.89%	66.53%	52.9%	126.66%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Immunoprecise Antibodies Ltd	NA	NA	NA	0.0	-0.66	-0.14	NA	1.08
Regeneron Pharmaceuticals, Inc.	17.86	17.86	1.01	43.09	0.16	0.07	0.01	273.57
Beone Medicines Ltd	NA	NA	NA	1.43	-0.19	-0.06	NA	31.22
Vertex Pharmaceuticals Incorporated	32.84	NA	1.34	18.07	-0.03	0.13	NA	63.87
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	0.57	-15.01	-0.03	NA	0.52

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Immunoprecise Antibodies Ltd	Buy	$16.1M	-97.53%	NA	-115.93%
Regeneron Pharmaceuticals, Inc.	Buy	$73.8B	44.83%	17.86	31.07%
Beone Medicines Ltd	NA	$29.1B	71.3%	NA	-16.92%
Vertex Pharmaceuticals Incorporated	Buy	$124.9B	123.83%	32.84	-4.86%
Alnylam Pharmaceuticals, Inc.	Buy	$31.4B	126.66%	NA	-12.37%

About Immunoprecise Antibodies

ImmunoPrecise Antibodies Ltd. is a biotechnology company that leverages multi-omics modeling and artificial intelligence through a series proprietary and patented technologies. The company owns an integrated end-to-end suite of capabilities to support the development of therapeutic antibodies and are known for solving industry challenges. It provides NonaVac DNA for complex protein classes, including GPCRs and ion channels; and Rapid Prime, positive monoclonal antibodies for generating anti-idiotypic antibodies, and producing monoclonal antibodies against conformational epitopes. The company also offers syngeneic cell line for immunization and screening; peptide production for subsequent antibody discovery campaign; B cell select platform, which allows for the interrogation of animal antibody repertoire; screening of the immune repertoire of rabbits and chickens and desired antibody directly from the B cells; single step hybridoma, a semi-solid media to grow mouse and rat hybridomas; and DeepDisplay, a combination of transgenic animal platform and custom IPA phage display antibody selection. In addition, it provides phage display, a custom immune library; CAR development, an adaptable antibody, which allows the inclusion of functional data early in the screening funnel; antibody sequencing; and assay development. Further, it offers a profiling toolset for antibody lead candidates; and in vitro analytical tools for the study of quality attributes. Additionally, it provides LucinaTech, an antibody humanization to identify framework and CDR residues; antibody affinity maturation for therapeutic and diagnostic application; antibody chimerization for cloning and production of antibody domain; Eurofins preclinical services; hybrid service model designed to reduce time and risk with custom applications; breadth and depth to accelerate assay development, screening cascades, drug candidate validation, and new biotherapeutic concepts; and protein manufacturing services. The company was founded in 1983 and is headquartered

Organization	Immunoprecise Antibodies
Employees	72
CEO	Dr. Jennifer Lynne Bath Ph.D.
Industry	Miscellaneous

Management People of Immunoprecise Antibodies

Name	Title
Dr. Jennifer Lynne Bath Ph.D.	CEO, President & Non-Independent Director
Dr. Ilse Roodink	Chief Scientific Officer & Interim General Manager of IPA Europe, Oss
Ms. Kari Graber	Vice President of Commercial Services
Mr. Joseph Scheffler	Interim Chief Financial Officer

Important FAQs about investing in IPA Stock from India :

What is Immunoprecise Antibodies share price today?

Immunoprecise Antibodies share price today stands at $0.39, Open: $0.35 ; Previous Close: $0.35 ; High: $0.40 ; Low: $0.33 ; 52 Week High: $2.43 ; 52 Week Low: $0.27.

The stock opens at $0.35, after a previous close of $0.35. The stock reached a daily high of $0.40 and a low of $0.33, with a 52-week high of $2.43 and a 52-week low of $0.27.

Can Indians buy Immunoprecise Antibodies shares?

Yes, Indians can invest in the Immunoprecise Antibodies (IPA) from India.

With INDmoney, you can buy Immunoprecise Antibodies at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Immunoprecise Antibodies at zero transaction cost.

How can I buy Immunoprecise Antibodies shares from India?

It is very easy to buy Immunoprecise Antibodies from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Immunoprecise Antibodies (IPA) be purchased?

Yes, you can buy fractional shares of Immunoprecise Antibodies with INDmoney app.

What are the documents required to start investing in Immunoprecise Antibodies stocks?

To start investing in Immunoprecise Antibodies, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.